Form 4 for ALDX Aldeyra Therapeutics, Inc.
Accepted 2024-10-21 00:00:00 ET · period of report 2021-05-03 · accession 0000950170-24-116048 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2024-10-21 | 2021-05-03+ | ALDX | Miller-Rich Nancy | Dir | P - Purchase | $11.33 | +922 | 922 | New | +$10.4K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-05-03 | P | A | 413 | $12.81 | 413 | D | — | — | |
| 2 | Common | Common Stock | 2023-04-12 | P | A | 509 | $10.13 | 922 | D | — | — |